Holen Sie sich die Stockscreener-App
3.12
6.85%
0.20
Handel nachbörslich:
3.11
-0.01
-0.32%
Schlusskurs vom Vortag:
$2.92
Offen:
$2.92
24-Stunden-Volumen:
137.93K
Relative Volume:
0.01
Marktkapitalisierung:
$18.42M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-9.32M
KGV:
-0.2455
EPS:
-12.7107
Netto-Cashflow:
$-7.30M
1W Leistung:
+3.31%
1M Leistung:
-0.64%
6M Leistung:
+165.64%
1J Leistung:
+57.58%
1-Tages-Spanne:
$2.80
$3.1499
1-Wochen-Bereich:
$2.78
$3.52
52-Wochen-Spanne:
$0.952
$9.08
Tharimmune Inc Stock (THAR) Company Profile
Firmenname
Tharimmune Inc
Sektor
Branche
Telefon
302-743-2995
Adresse
1200 ROUTE 22 EAST, BRIDGEWATER
Vergleichen Sie THAR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
THAR
Tharimmune Inc
|
3.12 | 19.88M | 0 | -9.32M | -7.30M | -12.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Tharimmune Inc Aktie (THAR) Neueste Nachrichten
Leading vs lagging indicators on Tharimmune Inc. performanceJuly 2025 Volume & Reliable Price Breakout Alerts - newser.com
Volume spikes in Tharimmune Inc. stock – what they mean2025 Top Decliners & Reliable Price Breakout Alerts - newser.com
Published on: 2025-10-14 00:55:23 - newser.com
Is Tharimmune Inc. still worth holding after the dipJuly 2025 Fed Impact & Community Verified Trade Signals - newser.com
Published on: 2025-10-13 08:55:39 - newser.com
Smart tools for monitoring Tharimmune Inc.’s price actionJuly 2025 WrapUp & Long-Term Safe Return Strategies - newser.com
Measuring Tharimmune Inc.’s beta against major indicesJuly 2025 Decliners & Fast Gaining Stock Strategy Reports - newser.com
Is now a turning point for Tharimmune Inc.Market Sentiment Review & Free Technical Pattern Based Buy Signals - newser.com
Tharimmune increases authorized common shares to 1 billion By Investing.com - Investing.com Nigeria
Tharimmune Increases Authorized Shares to 1 Billion - TipRanks
Tharimmune Stockholders Approve Key Strategic Proposals - TipRanks
Can volume confirm reversal in Tharimmune Inc.Weekly Investment Report & Entry Point Confirmation Signals - newser.com
Weiss Ratings Reaffirms Sell (E+) Rating for Tharimmune (NASDAQ:THAR) - Defense World
What analysts say about Tharimmune Inc stockShort Selling Opportunities & Exceptional Profit Growth - earlytimes.in
Tharimmune Inc Stock Analysis and ForecastOptions Trading Strategies & Affordable Trading Strategies - earlytimes.in
Candlestick signals on Tharimmune Inc. stock todayTrade Exit Summary & Reliable Intraday Trade Alerts - newser.com
Tharimmune Amends Warrants Agreement to Boost Liquidity - TipRanks
Tharimmune amends warrants to make 3.4 million shares immediately exercisable - Investing.com
Analyzing recovery setups for Tharimmune Inc. investorsMarket Weekly Review & Fast Exit/Entry Strategy Plans - newser.com
Tick level data insight on Tharimmune Inc. volatilityJuly 2025 Momentum & Free Fast Entry Momentum Trade Alerts - newser.com
What does recent volatility data suggest for Tharimmune Inc.Gap Down & Comprehensive Market Scan Insights - newser.com
Why Tharimmune Inc. is moving todayWeekly Gains Summary & Safe Entry Point Identification - newser.com
Wall Street Zen Upgrades Tharimmune (NASDAQ:THAR) to Hold - Defense World
Tharimmune (NASDAQ:THAR) Trading Down 2.1% – What’s Next? - Defense World
Pleasing Signs As A Number Of Insiders Buy Tharimmune Stock - Yahoo Finance
Tharimmune Secures Key Global Patents for TH-104, Laying Foundation for Broader Indications Following Initial Development as a National Security Medical Countermeasure Against Weaponized Fentanyl - El Paso Times
Is Tharimmune Inc a good long term investmentRisk Adjusted Returns & Capital Efficiency Improvement - earlytimes.in
Finanzdaten der Tharimmune Inc-Aktie (THAR)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):